| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/24/2008 | US7390621 Methods and compositions for detecting telomerase activity |
| 06/24/2008 | US7390620 Screening method for anti-microbial drug targets by genome-saturating mutagenesis (GSM) |
| 06/24/2008 | US7390619 Creating a library of mutant polynucleotides from at least two nucleic acids encoding a B7-1 (CD80) protein; expressing in cells and screening for the optimized polynucleotide; increased T-cell response, increased activity through CD28 and a decreased activity through CTLA-4 |
| 06/24/2008 | US7390495 Neurovirulent strain of the West Nile virus and uses thereof |
| 06/24/2008 | US7390486 PRO4381 antibodies |
| 06/24/2008 | US7390485 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders |
| 06/24/2008 | US7390463 Apparatus for use detection of preferential particles in sample |
| 06/24/2008 | US7390458 Provides flexibility, robustness, accuracy |
| 06/24/2008 | US7390391 Constructing a reaction system including a test target, an oxidation-reduction enzyme, and a Ru compound as an electron mediator, and measuring the concentration of the test target by an electrochemical process |
| 06/19/2008 | WO2008074023A2 Systems and methods for multiplex analysis of pcr in real time |
| 06/19/2008 | WO2008073923A2 Mirna regulated genes and pathways as targets for therapeutic intervention |
| 06/19/2008 | WO2008073899A2 Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis |
| 06/19/2008 | WO2008073890A2 Buffer composition |
| 06/19/2008 | WO2008073878A2 Gene expression profiling of esophageal carcinomas |
| 06/19/2008 | WO2008073816A2 System and method for detection of substances |
| 06/19/2008 | WO2008073805A1 Secretable reporter system |
| 06/19/2008 | WO2008073635A2 Automatable artificial immune system (ais) |
| 06/19/2008 | WO2008073629A2 Bifunctional predictors of cancer treatment sensitivity and resistance |
| 06/19/2008 | WO2008073624A2 Quantitative nucleic acid hybridization using magnetic luminescent particles |
| 06/19/2008 | WO2008073619A2 Wnt pathway mutations in cancer stem cells |
| 06/19/2008 | WO2008073457A2 Methods for determining prognoses and therapeutic interventions for ovarian carcinomas |
| 06/19/2008 | WO2008073331A2 Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue |
| 06/19/2008 | WO2008073316A2 Identification and isolation of acute myeloid leukemia stem cells |
| 06/19/2008 | WO2008073290A1 Tp53 gene expression and uses thereof |
| 06/19/2008 | WO2008073201A2 Compositions and methods for identifying agents that alter expression of survivin |
| 06/19/2008 | WO2008073177A2 Expression profiles associated with irinotecan treatment |
| 06/19/2008 | WO2008073175A2 Nanoplasmonic molecular ruler for nuclease activity and dna footprinting |
| 06/19/2008 | WO2008073165A2 Methods and compositions for identifying anti-hcv agents |
| 06/19/2008 | WO2008072777A2 Ttk as tumor marker and therapeutic target for lung cancer |
| 06/19/2008 | WO2008072741A1 Cancer test method, cancer test kit, and cancer test agent |
| 06/19/2008 | WO2008072702A1 Method for measuring 1,5-anhydroglucitol in whole blood, and sensor chip and measurement kit to be used in the method |
| 06/19/2008 | WO2008072242A2 Compositions and methods for concentrating and depleting microorganisms |
| 06/19/2008 | WO2008072217A2 Nucleic acids probes for detection of yeast and fungal species |
| 06/19/2008 | WO2008072209A2 Method and microdevice to identify and/or quantify analytes in biological samples |
| 06/19/2008 | WO2008072192A2 Biological assay substrate and method and device for producing such substrate |
| 06/19/2008 | WO2008071998A2 Diagnostic methods for diseases caused by a hpv infection comprising determining the methylation status of the hpv genome |
| 06/19/2008 | WO2008071982A2 Electrode systems and their use in the characterization of molecules |
| 06/19/2008 | WO2008071910A2 Cytokeratin acetylation and detection of hdac5 |
| 06/19/2008 | WO2008071749A2 Internalization |
| 06/19/2008 | WO2008071721A1 Rapid test for detecting dna sequences |
| 06/19/2008 | WO2008071385A2 Use of acetals for the isolation of nucleic acids |
| 06/19/2008 | WO2008071345A1 Rapid immune chromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071344A1 Antibody detection method involving oligonucleotide enhanced colloidal gold signal |
| 06/19/2008 | WO2008071343A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071342A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071341A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071340A1 Antigen detection method involving an oligonucleotide enhanced colloidal gold signal |
| 06/19/2008 | WO2008071339A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071336A1 Urinary immunochromatographic multiparameter detection cup |
| 06/19/2008 | WO2008071335A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071334A1 Rapid immunochromatographic detection by amplification of the colloidal gold signal |
| 06/19/2008 | WO2008071242A1 Method for inducing tumor apoptosis by increasing nitric oxide levels |
| 06/19/2008 | WO2008070924A1 A method of drug design |
| 06/19/2008 | WO2008054828A9 Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma |
| 06/19/2008 | WO2008054394A3 Method and apparatus for detection of toxic agents using photosynthetic organisms |
| 06/19/2008 | WO2008052558A3 Predisposition to, prognosis for and treatment regime for breast cancer using genetic markers on chromosome 13 |
| 06/19/2008 | WO2008051742A3 Transient decay amperometry |
| 06/19/2008 | WO2008050064A3 Method for molecular identification and genotyping of bacteria of the mycobacterium tuberculosis complex |
| 06/19/2008 | WO2008046189A9 Proteins involved in after-cooking darkening in potatoes |
| 06/19/2008 | WO2008044129A3 Double-stranded probes for the fluorescent detection of nucleic acids |
| 06/19/2008 | WO2008041002A3 Method for sequencing a polynucleotide template |
| 06/19/2008 | WO2008037930A3 Method for the in vitro diagnosis of bronchopulmonary carcinoma by detecting major alternative transcripts of the klk8 gene encoding kallicrein 8 and use thereof for prognosticating survival |
| 06/19/2008 | WO2008036273A3 Receptor family profiling |
| 06/19/2008 | WO2008032323A3 Method of determining lymph node metastasis |
| 06/19/2008 | WO2008031017A3 Supramolecular metallic complexes exhibiting both dna binding and photocleavage |
| 06/19/2008 | WO2008030433A3 Chip and cartridge design configuration for performing micro-fluidic assays |
| 06/19/2008 | WO2008029110A3 Electrochemical device with 3 detection areas |
| 06/19/2008 | WO2008028965A3 Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses thereof |
| 06/19/2008 | WO2008010928A3 Method for discovery of anti-senescence genes |
| 06/19/2008 | WO2007130523A3 Compositions and methods for detecting and treating hiv infection |
| 06/19/2008 | WO2007121276A3 Enrichment of circulating fetal dna |
| 06/19/2008 | WO2007117282A3 Lactic acid-producing yeast cells having nonfunctional l-or d-lactate: ferricytochrome c oxidoreductase gene |
| 06/19/2008 | WO2007108841A3 Method for identifying drug-sensitizing antisense dna fragments and use thereof |
| 06/19/2008 | WO2007100631A3 Compositions and methods for modulating cytokine production |
| 06/19/2008 | WO2007090124A3 Methodologies for the diagnosis and treatment of gastroesophageal reflux disease |
| 06/19/2008 | WO2006005074A3 Novel hot start nucleic acid amplification |
| 06/19/2008 | WO2001034766A3 Protein monitoring the activity of small gtp-binding protein |
| 06/19/2008 | US20080148430 Using transgenic plants as bioreactor for measuring or detecting mitogen-activated protein (MAP) kinase activity |
| 06/19/2008 | US20080148416 Animal models for monitoring activity of drug metabolizing enzymes; side effect reduction; assessing xenobiotics |
| 06/19/2008 | US20080147199 Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof |
| 06/19/2008 | US20080146900 Method and apparatus for providing power management in data communication systems |
| 06/19/2008 | US20080146791 Solid support comprising immobilized receptors for use in isolating preferential nucleotide sequences in solution |
| 06/19/2008 | US20080146785 Antibody against tumor specific antigen as target |
| 06/19/2008 | US20080146781 Modified Human Four Helical Bundle Polypeptides and Their Uses |
| 06/19/2008 | US20080146594 Thrombopoietin activity modulating compounds and methods |
| 06/19/2008 | US20080146540 Identifying genetically at risk persons having MAP3K9 associated presence; kits; assay techniques; treating with mixed lineage kinase inhibitors |
| 06/19/2008 | US20080146532 Drug Screening and Treatment Methods |
| 06/19/2008 | US20080146512 cell cycle control by administering opioid growth factor (OGF), which activates opioid growth factor receptor (OGFr) signaling. , the present invention provides a method for monitoring OGF modulation or treatment of a cell proliferation or growth related condition in a subject by assessing the kinase |
| 06/19/2008 | US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor |
| 06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
| 06/19/2008 | US20080146505 47 Human Secreted Proteins |
| 06/19/2008 | US20080146499 Identification of the Precise Amino Acid Sequence of the Epitope Recognized by the Potent Neutralizing Human Anti-Hiv-1 Monoclonal Antibody Igg1b12 |
| 06/19/2008 | US20080146488 strongly immunogenic polypeptide to a more weakly immunogenic polypeptide can precipitate and focus a CpG adjuvant to increase in vivo priming of a cytotoxic T-lymphocyte (CTL) response, and thus increase the immunogenicity of the more weakly immunogenic polypeptide |
| 06/19/2008 | US20080146460 Optical probes and assays |
| 06/19/2008 | US20080146458 Process for the preparation of oxazolidinones and method of use thereof |
| 06/19/2008 | US20080146457 Method for the determination of cell activation |
| 06/19/2008 | US20080146455 Methods for identification of sepsis-causing bacteria |
| 06/19/2008 | US20080146447 Applying to crop plants and weeds a pyruvic acid dioxygenase inhibitor to control weeds without affecting the growth |
| 06/19/2008 | US20080145943 Cng2b: a novel human cyclic nucleotide-gated ion channel |
| 06/19/2008 | US20080145935 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |